Dr. Mothaffar Rimawi, MD
Claim this profileBaylor College of Medicine
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
23 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage IV
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Mothaffar Rimawi, MD is currently running
Chemotherapy Response Prediction
for Breast Cancer
The purpose of this study is to learn whether clinical response (the amount a tumor shrinks based on imaging or tumor measurements obtained by physical exam) predicts pathologic response (the amount of tumor remaining when surgery is performed) in participants with breast cancer who are receiving chemotherapy prior to surgery.
Recruiting1 award Phase 2
GLSI-100
for HER2 Positive Breast Cancer
This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk for disease recurrence and have completed both neoadjuvant and postoperative adjuvant standard of care therapy. Treatment consists of 6 intradermal injections, Primary Immunization Series (PIS), over the first 6 months of treatment and 5 booster intradermal injections spaced 6 months apart. A third open-label arm will explore GLSI-100 immunotherapy in non-HLA-A\*02 positive and HER2/neu positive subjects.
Recruiting1 award Phase 36 criteria
More about Mothaffar Rimawi, MD
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mothaffar Rimawi, MD has experience with
- Paclitaxel
- Pertuzumab
- Trastuzumab
- Placebo
- Tucatinib
- TAA-specific CTLs
Breakdown of trials Mothaffar Rimawi, MD has run
Breast Cancer
Breast cancer
Lobular Carcinoma in Situ
Ductal Carcinoma In Situ
Atypical Lobular Hyperplasia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mothaffar Rimawi, MD specialize in?
Mothaffar Rimawi, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Mothaffar Rimawi, MD currently recruiting for clinical trials?
Yes, Mothaffar Rimawi, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Mothaffar Rimawi, MD has studied deeply?
Yes, Mothaffar Rimawi, MD has studied treatments such as Paclitaxel, Pertuzumab, Trastuzumab.
What is the best way to schedule an appointment with Mothaffar Rimawi, MD?
Apply for one of the trials that Mothaffar Rimawi, MD is conducting.
What is the office address of Mothaffar Rimawi, MD?
The office of Mothaffar Rimawi, MD is located at: Baylor College of Medicine, Houston, Texas 77030 United States. This is the address for their practice at the Baylor College of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.